• Jobs
  • Startups
  • Hire
LoginSign up

Alloy Therapeutics

Alloy Therapeutics has 12 open roles, 3 posted in the last 30 days. Stated pay range: $93k – $335k a year. Funding stage: Series E. Last round: $40M, Apr 15, 2026.

Open roles

  • Alloy Therapeutics logo
    Associate Director, Antibody Discovery

    Alloy Therapeutics

    • Athens, GA
    • On-site · Director / Executive
    • $130k–$155k
    JazzHR
    Posted 1d ago
  • Alloy Therapeutics logo
    VP, Strategy & Business Operations

    Alloy Therapeutics

    • Waltham, MA
    • Director / Executive
    • $245k–$335k
    JazzHR
    Posted 22d ago
  • Alloy Therapeutics logo
    Senior Executive Assistant, Technology & National Security

    Alloy Therapeutics

    • Waltham, MA
    • Hybrid · Senior
    • $135k–$155k
    AI-native
    JazzHR
    Posted 22d ago
  • Alloy Therapeutics logo
    82VS Venture Partner

    Alloy Therapeutics

    • Waltham, MA
    • On-site · Director / Executive
    • $265k–$325k
    JazzHR
    Posted 46d ago
  • Alloy Therapeutics logo
    Associate Director - Antibody Discovery Programs

    Alloy Therapeutics

    • Waltham, MA
    • On-site · Director / Executive
    • $150k–$200k
    JazzHR
    Posted 60d ago
  • Alloy Therapeutics logo
    Director, Protein Science

    Alloy Therapeutics

    • Waltham, MA
    • On-site · Director / Executive
    • $170k–$200k
    JazzHR
    Posted 70d ago
Show all roles

About

Alloy Therapeutics logo

Alloy Therapeutics

May The Best Drug Win

Alloy Therapeutics is a Product Development Organization dedicated to helping the global scientific community make better medicines together. We provide the integrated platforms, data, and capabilities partners need to advance medicines from discovery through development—without building a competing proprietary pipeline of our own. Trusted by more than 200 partners worldwide, including 18 of the top 50 biopharmaceutical companies, Alloy works side by side with innovators to enable the discovery and development of their next breakthrough medicines. With Alloy, partners can: • Discover antibodies and complex biologics through an expanding portfolio of in vivo and in vitro platforms integrated with AI, machine learning, and high-throughput experimentation. • Unlock intracellular targets through Keyway™, our fully integrated T cell receptor mimic (TCRm) discovery and development capabilities. • Advance next-generation RNA medicines using the AntiClastic™ cyclic RNA platform and our integ

Private companySeries E
Founded2017
HQBoston, United States
Unlock human wisdom
ThesisTermsPrivacy
Size
51–200 employees
IndustryBiotechnology Research
Funding
  • Series E · $40M · Apr 15, 2026
Investors
8VCJIC Venture Growth InvestmentsEcho CapitalAlexandria Venture InvestmentsFounders Fund

Claim alloytx.com

Work at alloytx.com? Sign in to claim this org and manage its profile.

© 2026 Saywise Inc.